Cardiovascular Risk Factors and Haematological Indexes of Inflammation in Paralympic Athletes with Different Motor Impairments

Table 3

Endogenous antioxidants and other clinically relevant markers.

	PA-SCI-H ()	PA-SCI-L ()	PA-LLA ()	PA-ULI ()
UA (mg/dL)	5.6 (5.1-6.5)	6.0 (5.1-6.6)	5.8 (5.3-6.2)	5.4 (4.2-6.2)
UA/Cr	7.3 (6.5-8.2) vs. ULI	7.8 (5.7-9.1) vs. ULI	5.9 (5.8-6.8)	5.6 (4.4-5.7)
BR (mg/dL)	0.4 (0.3-0.6)	0.5 (0.5-0.7)	0.6 (0.5-0.8)	0.9 (0.6-1.4) vs. SCI-H
RBC (10^6/microL)
Hb (g/dL)			vs. SCI-H	vs. SCI-H
HCT (%)		vs. SCI-H	vs. SCI-H
MCV (fL)
MCH (pg)	29.2 (28.4-30.5)	28.6 (27.5-30.0)	29.9 (29.3-31.4)	29.4 (28.9-29.9)
PMCHR
MCHC (g/dL)
Iron (mcg/dL)
Urea (mg/dL)
Cr (mg/dL)	vs. ULI vs. LLA	vs ULI vs. LLA
Proteins (g/dL)			vs. SCI-H	vs SCI-H
CPK (U/L)	161 (98-218)	197 (148-296)	142 (109-185)	152 (139-331)

UA: uric acid, BR: bilirubin, CR: creatinine, RBC: red blood cells, Hb: haemoglobin, HCT: haematocrit, MCV: mean corpuscular volume, MCH: mean cell haemoglobin, MCHPR: MCH/platelet ratio, MCHC: mean cell haemoglobin concentration, CPK: creatine phosphokinase. Data are expressed as mean and SEM (normality test (Shapiro-Wilk) passed; One Way Analysis of Variance, followed by All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method)) or median and interquartile range (25%-75%) (normality test (Shapiro-Wilk) failed; Kruskal-Wallis One Way Analysis of Variance on, followed by All Pairwise Multiple Comparison Procedures (Dunn’s Method)).